The trailing twelve-month analysis sheds further light on Biohaven?s financial integrity. Cumulative Current Liabilities soared to $164.034 million in Q1 2025, forcing the Working Capital Ratio downward to 2.99 well below Biohaven's own trailing twelve-month average.